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Melanocytes, the pigment-producing cells, arise from multipotent neural crest (NC) cells during
embryogenesis. Many genes required for melanocyte development were identiﬁed using mouse pig-
mentation mutants. The variable spotting mouse pigmentation mutant arose spontaneously at the Jack-
son Laboratory. We identiﬁed a G-to-A nucleotide transition in exon 3 of the Ets1 gene in variable
spotting, which results in a missense G102E mutation. Homozygous variable spotting mice exhibit
sporadic white spotting. Similarly, mice carrying a targeted deletion of Ets1 exhibit hypopigmentation;
nevertheless, the function of Ets1 in melanocyte development is unknown. The transcription factor Ets1 is
widely expressed in developing organs and tissues, including the NC. In the chick, Ets1 is required for the
expression of Sox10, a transcription factor critical for the development of various NC derivatives,
including melanocytes. We show that Ets1 is required early for murine NC cell and melanocyte precursor
survival in vivo. Given the importance of Ets1 for Sox10 expression in the chick, we investigated a
potential genetic interaction between these genes by comparing the hypopigmentation phenotypes of
single and double heterozygous mice. The incidence of hypopigmentation in double heterozygotes was
signiﬁcantly greater than in single heterozygotes. The area of hypopigmentation in double heterozygotes
was signiﬁcantly larger than would be expected from the addition of the areas of hypopigmentation of
single heterozygotes, suggesting that Ets1 and Sox10 interact synergistically in melanocyte development.
Since Sox10 is also essential for enteric ganglia development, we examined the distal colons of Ets1 null
mutants and found a signiﬁcant decrease in enteric innervation, which was exacerbated by Sox10 het-
erozygosity. At the molecular level, Ets1 was found to activate an enhancer critical for Sox10 expression in
NC-derived structures. Furthermore, enhancer activation was signiﬁcantly inhibited by the variable
spotting mutation. Together, these results suggest that Ets1 and Sox10 interact to promote proper mel-
anocyte and enteric ganglia development from the NC.
& 2015 Elsevier Inc. All rights reserved.Introduction
Melanocytes are derived from neural crest (NC) cells, a transient
population of multipotent cells that arises from the dorsal aspect of
the neural tube during vertebrate embryogenesis. In addition to
melanocytes, other NC-derived lineages include endocrine cells,
glial cells, neurons, craniofacial bone and cartilage, and cardiac cells
(Le Douarin and Kalcheim, 1999). Defects in NC cell developmentresult in a range of human disorders known as Neurocristopathies
(Bolande, 1997). These include craniofacial malformations, cardio-
and neurocutaneous syndromes, Waardenburg Syndrome, Hirsch-
sprung's disease, and piebaldism, among others (reviewed in Hou
and Pavan (2008) and Pingault et al. (2010)). Neurocristopathies are
often characterized by pigmentation defects, hence the study of
mouse pigmentation mutants has been instrumental for the iden-
tiﬁcation of genes and pathways involved in the development of
various NC cell lineages, including melanocytes (Tassabehji et al.,
1992; Hosoda et al., 1994; Puffenberger et al., 1994).
The deletion of the transcription factor Ets1was recently shown
to cause hypopigmentation in mice (Gao et al., 2010); however, the
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member of a large family of helix-turn-helix transcription factors
that are characterized by the presence of the E26 transforming
speciﬁc sequence (Ets) domain, which recognizes the core
nucleotide sequence GGAA/T (reviewed in Dittmer (2003)). Ets1 is
required for the survival of various cell lineages, including thy-
mocytes, T cells (Muthusamy et al., 1995), and endothelial cells
(Wei et al., 2009). During embryonic development, Ets1 is
expressed in various organs and tissues, including the NC (Van-
denbunder et al., 1989; Quéva et al., 1993; Kola et al., 1993; Mar-
oulakou et al., 1994; Fafeur et al., 1997; Théveneau and Mayor,
2007). Ets1 expression has also been correlated with pathological
invasive processes. This transcription factor has been found to be
upregulated in various tumor types, including melanoma (Keehn
et al., 2003; Rothhammer et al., 2004, 2005; reviewed in Garrett-
Sinha (2013)), and its expression in certain tumors has been cor-
related with the upregulation of matrix metalloproteases (MMPs),
particularly MMP1, MMP2 and MMP9 (Rothhammer et al. (2004),
and Okuducu et al. (2006); reviewed in Dittmer (2003)).
Several studies have implicated Ets1 in the proper development of NC
cell derivatives. During chick embryonic development, Ets1 expression is
correlated with epithelial-to-mesenchymal transition (EMT) (Fafeur et al.,
1997), and although it is not required for EMT, Ets1 promotes cell
mobilization, which is necessary for the initiation of cranial NC cell
delamination (Théveneau et al., 2007). In the mouse, Ets1 deletion was
found to produce cardiac malformations (Gao et al., 2010; Ye et al., 2010).
Some of these cardiac malformations were found to arise as a result of
the lack of NC-derived cells in the proximal aspects of the outﬂow tract
endocardial cushions and the presence of an abnormal nodule of NC-
derived cartilage within the heart. These defects suggest a role for Ets1 in
proper NC cell migration and differentiation (Gao et al., 2010).
The exact mechanism by which Ets1 deﬁciency during embryonic
development results in hypopigmentation has not been elucidated.
In the chick cranial NC, Ets1 is required for the activation of the
transcription factor sex determining region Y (SRY)-box 10 (Sox10)
(Betancur et al., 2010), a gene required for the development of var-
ious NC cell derivatives, including melanocytes and enteric ganglia
(Herbarth et al., 1998; Southard-Smith et al., 1998; Kapur, 1999;
Potterf et al., 2001). In humans, mutations in Sox10 are responsible
for Waardenburg syndrome type IV, which is characterized by pig-
mentation defects and aganglionosis of the distal colon (Hirsch-
sprung's disease) (Pingault et al., 1998). The requirement of Ets1 for
Sox10 expression in the chick embryo and the hypopigmentation
phenotype of Ets1 null mutants, suggest that Ets1 may play an
important role in the regulation of this and other melanocyte-spe-
ciﬁc genes in the mouse embryo.
In the present study, we report the identiﬁcation of Ets1 as the
mutated gene in the spontaneous variable spotting mouse pig-
mentation mutant. This ﬁnding, along with the observation that
mice carrying a targeted deletion of Ets1 have belly spots (Gao
et al., 2010), suggested a role for Ets1 in melanocyte development.
We characterized the temporal requirement of Ets1 for melanocyte
development and established a role for this transcription factor in
NC and melanocyte precursor (melanoblast) survival. In light of
the functional relationship that exists between Ets1 and Sox10 in
the chick cranial NC, we hypothesized that, in the mouse, Ets1may
interact with Sox10 to promote melanocyte development. Analysis
of the pigmentation phenotype of single and double heterozygous
mutants for Ets1 and Sox10 revealed a synergistic genetic inter-
action between these transcription factors. Given the importance
of Sox10 for enteric ganglia development, we also investigated the
effect of Ets1 deﬁciency on enteric innervation. Analysis of the
distal colons of Ets1 null mutant mice revealed defects in enteric
ganglia patterning, which were further exacerbated by Sox10
heterozygosity, hinting to a potential interaction between Ets1 and
Sox10 in the development of enteric ganglia. Using in vitro assays,we show that Ets1 is able to activate an enhancer critical for Sox10
expression in NC-derived lineages. Additionally, mutating Ets1, at
the site we characterized in the variable spotting mutant, reduces
the ability of Ets1 to activate this Sox10 enhancer. Together, our
results indicate that Ets1 is required early for NC cell and mela-
noblast survival. Furthermore, the presence of a synergistic genetic
interaction between Ets1 and Sox10 in melanocyte development,
and the ability of Ets1 to activate a Sox10 regulatory region, sug-
gests that at least some of the functions of Ets1 in melanocyte
development may be mediated by Sox10.Materials and methods
Ethics statement
All animal work was approved by the Florida International
University Institutional Animal Care and Use Committee (Protocol
no. 13-064) and performed according to institutional guidelines
established by the National Institutes of Health (NIH) (Guide for
the Care and Use of Laboratory Animals, 2011).
Exome and direct sequencing of the variable spotting mutation
A single heterozygous variable spotting sample was processed
for exome sequencing. Whole genome libraries with 170 base
inserts and paired-end index adapters were prepared from 3 mg
DNA using a SPRI-TE robot and reagents (Beckman-Colter).
Libraries were enriched using the SureSelect Mouse All Exon Kit
(Agilent) and pooled for sequencing in 2 lanes on a HiSeq2000
(Illumina) using version 3 chemistry. At least 50 million paired-
end 100 base reads were obtained for each sample. Data was
processed using RTA version 1.12.4.2 and CASAVA 1.7.0. Sequencing
reads were aligned with ELAND, and then realigned with cross_-
match (http://www.phrap.org) to the UCSC mm9 mouse reference
sequence. After removal of PCR duplicate reads, diploid genotypes
were called using bam2mpg (Teer et al., 2010). Variants were
annotated against the UCSC “known genes” gene set (Hsu et al.,
2006) using ANNOVAR (http://www.openbioinformatics.org/anno
var), and genotypes, gene annotations, and dbSNP (build 128)
identiﬁers were reported in VarSifter format for viewing and ﬁl-
tering (Teer et al., 2012).
Filtering variants to those in coding exons or splice sites within
the variable spotting interval (Chr 9 proximal to Apoa1; Spencer
and Davisson, 1988) identiﬁed 2 variants with heterozygote gen-
otype calls not present in dbSNP or 4 other unrelated mouse
mutant exomes completed as part of the same project. The 2 var-
iants were within Mtmr2 (c.1757G4A:p.R586Q; CDPred score 1)
and Ets1 (c.305G4A:p.G102E; CDPred score 11). CDPred is an
algorithm designed to predict the effect of amino acid substitu-
tions (Johnston et al., 2010) with scores above 3, as observed for
the Mtmr2 variant, predicted to have a mild/neutral effect and
scores below 7, as observed for Ets1, predicted to have a severe
effect on protein function. The CDPred predictions are consistent
with SIFT (Kumar et al., 2009), a second tool which predicts the
Mtmr2 variant to be tolerated (SIFT score¼0.07) compared to the
deleterious Ets1 variant (SIFT score¼0). To conﬁrm Ets1 as the
gene responsible for the variable spotting phenotype we used an
independent targeted Ets1 allele to conﬁrm that Ets1 deﬁciency
alone is sufﬁcient to cause hypopigmentation, providing strong
evidence that the Ets1 variant is causative for the phenotype
observed in variable spotting mice.
DNA samples from 2 heterozygous and 2 homozygous variable
spottingmutant mice were purchased from The Jackson Laboratory
(Bar Harbor, Maine). A 496 bp DNA fragment surrounding the
suspected mutation was ampliﬁed via PCR using the primers 5′-
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GAAGAAAATAAG. PCR products were puriﬁed using ExoSAP-IT
(Afﬁmetryx), following the manufacturer's instructions, and
directly sequenced. Sequences were analyzed using the Applied
Biosystems Sequence Scanner v1.0 software (Applied Biosystems)
and sequence alignments against the Mus musculus genomic
database were carried out via the Nucleotide BLAST server (NCBI,
NIH). Multiple alignments to the Ets1 protein sequences for
human, rat, zebraﬁsh, dog, and mouse were carried out using
ClustalW (via ExPASy.org).
Animals and genotyping
Ets1 mutant mice were a kind gift from Dr. Eric Svensson
(University of Chicago, Chicago, IL). They were generated as pre-
viously described (Barton et al., 1998), and re-derived by out-
crossing to C57BL/6J mice for eight generations (Gao et al., 2010).
They have been maintained on C57BL/6J genetic background by
intercrossing and by outcrossing to C57BL/6J mice (Jackson
Laboratories). Mice carrying the Dct-LacZ transgene (Tg(Dct-lacZ)
#Ove) were obtained from Dr. Paul Overbeek (Baylor College of
Medicine, Houston, TX) and generated on an FVB/N genetic back-
ground, as previously described (Zhao and Overbeek, 1999). Dct-
LacZ mice were maintained by intercrossing and bred with Ets1
heterozygotes to generate Ets1þ /::Dct-LacZþ mice, which were
intercrossed for the generation of embryos. Sox10tmlWeg/Sox10þ
mice (hereafter referred to as Sox10LacZ/þ) were obtained from Dr.
Michael Wegner (Institut für Biochemie, Universität Erlangen-
Nürnberg, Germany) and generated on a mixed genetic back-
ground (129S1/Sv; C3HeB/FeJ; C57BL/6J), as previously described
via insertion of the LacZ gene into the Sox10 coding sequence
(Britsch et al., 2001). Sox10LacZ/þ mice were maintained by inter-
crossing and bred with Ets1 heterozygotes to generate double
heterozygotes.
Genomic DNAwas isolated from tail biopsies or yolk sacs, and used
for genotyping by PCR. Genotyping for Ets1 was performed as pre-
viously described (Gao et al., 2010). For Sox10LacZ, genotyping of was
performed using the primers 5′-CAGGTGGGCGTTGGGCTCTT, 5′-
CAGAGCTTGCCTAGTGTCTT, and 5′-TAAAAATGCGCTCAGGTCAA (Britsch
et al., 2001). Dct-LacZmice were genotyped via β-galactosidase staining
of ear tips, using standard protocols (Nagy et al., 2003).
β-Galactosidase and Lysotracker Red staining of whole mouse
embryos
Embryos from intercrosses between Ets1þ /::Dct-LacZþ mice
were harvested between embryonic days (E) 10.75–E15.5.
Embryos from intercrosses between Ets1þ /::Sox10LacZ/þ mice
were harvested at E9.5, E11.5, and E12.5. Whole embryos were
subjected to β-galactosidase (LacZ) staining following standard
protocols (Nagy et al., 2003). For each stage, at least 3 embryos of
each genotype were stained and photographed. The staining was
visualized under a Leica MZ6 dissecting scope and photographed
using a Leica DC500 camera. In the case of E10.75 embryos,
Lysotracker Red staining was carried out prior to β-galactosidase
staining by incubating embryos in 5 mM Lysotracker Red DND-99
(Life Technologies) in PBS, protected from light, at 37 °C for
30 min. Subsequently, embryos were washed with PBS (pH7.2) and
LacZ staining was performed.
Immunoﬂuorescence
Freshly dissected E10.25 and E12.5 embryos were ﬁxed in 4%
paraformaldehyde for 3 and 16 h, respectively, at 4 °C, while
E10.75, LacZ and Lysotracker Red-stained, embryos were post-
ﬁxed in 4% paraformaldehyde for 20 min at room temperature.Embryos were then washed with PBS and incubated at 4 °C in 10%
sucrose for 4 h and in 20% sucrose, overnight. Embryos were
embedded in Tissue-Tek Tissue Freezing Medium (Sakura), frozen
at 80 °C, and sectioned at 10 mm. Sections were blocked with 1%
Bovine Serum Albumin (BSA), 0.1% Triton X-100 in PBS for 45 min
at room temperature and incubated in primary antibodies (diluted
in blocking solution) for 1 h at room temperature. Primary anti-
bodies include rabbit anti-phospho-Histone H3 (Ser10) (1:100;
Millipore, 06-570), goat polyclonal anti-Sox10 (1:100; Santa Cruz
Biotechnology, sc-17342), and rabbit anti-cleaved Caspase-3
(1:200; Cell Signaling, 9664S). After washing, sections were incu-
bated with a suitable ﬂuorescently-tagged secondary antibody
(goat anti-rabbit Alexa Fluor 488 (1:200; Life Technologies,
A11008), or donkey anti-goat Alexa Fluor 594 (1:200; Life Tech-
nologies, A11058)) for 1 h at room temperature. Sequential incu-
bation in secondary antibodies (donkey anti-goat Alexa Fluor 594
followed by goat anti-rabbit Alexa Fluor 488) was carried out for
Sox10 and cleaved Caspase-3 double-labeling in sections from
E10.25 embryos. Cell nuclei were counterstained with 1 mg/ml
Hoechst Dye (BioRad). The staining was visualized using a Leica
DMRB compound ﬂuorescent microscope. Sections were photo-
graphed using a Leica DC500 camera.
For E10.75 Ets1 /::Dct-LacZþ (n¼3) and Ets1þ /::Dct-LacZþ
(n¼3) embryos, melanoblasts (LacZ positive cells), dying melano-
blasts (LacZ and Lysotracker Red positive cells), and proliferating
melanoblasts (LacZ and phospho-Histone H3 positive cells) were
counted in 80 sections spanning the trunk region of each embryo.
For E10.25 Ets1 /(n¼3) and Ets1þ / (n¼3) embryos, NC cells
(Sox10 positive cells) and dying NC cells (Sox10 and cleaved Cas-
pase-3 positive cells) were counted in 35 sections spanning the
anterior half of the trunk region of each embryo. For E12.5 Ets1 /
(n¼3) and Ets1þ /þ (n¼3) embryos, Sox10 positive cells in the
dorsal root ganglia were counted in 15 sections spanning the trunk
region of each embryo. Data are shown as mean7standard devia-
tion. The Student's t-test was used to determine statistical sig-
niﬁcance. Data were considered statistically signiﬁcant at po0.05
Phenotypic and statistical analyses
Ets1þ / mice were crossed to Sox10LacZ/þ to generate progeny
that were either Ets1þ / , Sox10LacZ/þ , or Ets1þ /::Sox10LacZ/þ . The
single heterozygous progeny of the ﬁrst generation (F1) were
intercrossed to generate the second generation (F2) animals. Third
generation animals (F3) were generated by intercrossing single
heterozygous as well as double heterozygous F2 mice. For each
generation, the ventral aspects of each mouse were photographed
at 6 weeks of age. The areas of hypopigmentation were measured
using the ImageJ 1.44p program (NIH).
Statistical differences for the frequency of belly spot appear-
ance were determined using the Chi-square test. In order to
compare the mean areas of hypopigmentation among the different
genotypes, a Box–Cox transformation was applied to the belly spot
area data (measured in mm2). For each generation, the trans-
formed areas of hypopigmentation of Ets1þ /::Sox10LacZ/þ mice
were compared to the sum of the transformed areas of hypo-
pigmentation of Ets1þ / and Sox10LacZ/þ mice using a One-Way
ANOVA with a contrast. Scatter plots of the hypopigmentation
areas showing the mean and standard deviations for each group
were generated using GraphPad Prism 6 (GraphPad Software, Inc.).
Data were considered statistically signiﬁcant at po0.05.
Colon dissection and Acetylcholinesterase staining
Ets1þ / , Sox10LacZ/þ , and Ets1þ /::Sox10LacZ/þ mice were crossed
to generate progeny of the following genotypes: Ets1þ /::Sox10þ /þ ,
Ets1þ /::Sox10LacZ/þ , Ets1 /::Sox10þ /þ , and Ets1 /::Sox10LacZ/þ .
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7 months of age, were euthanized and their colons dissected.
Approximately 30 mm of the distal aspect of the colons of each
animal were removed, cleaned, and ﬁxed in 4% paraformaldehyde,
containing 10 mM CaCl2, overnight, at 4 °C. Subsequently, the colons
were brieﬂy washed with PBS (pH7.4) and incubated in 5% sucrose
for 24 h. The colons were then washed with PBS and subjected to
Acetylcholinesterase staining as previously described (Gariepy et al.,
1998). The staining was visualized under a Leica MZ6 dissecting
scope and photographed using a Leica DC500 camera. Colons from at
least 5 animals of each genotype were stained and photographed.
The extent of enteric innervation was quantiﬁed using the images
captured, by measuring the white (nerve-free) area in 8 squares of
0.25 mm2 each (for a total of 2 mm2 per colon), within a region
located 15 mm anterior to the anus. The ImageJ 1.44p program (NIH)
was used to measure the white areas in each segment of colon. The
Student's
t-test was used to compare the nerve-free areas of colons from mice
of the various genotypes listed above. Scatter plots of the nerve-free
areas in 2 mm2 of colon for each genotype, showing the mean and
standard deviations were generated using GraphPad Prism 6
(GraphPad Software, Inc.).
Vectors for luciferase assays
The Ets1 overexpression vector (pCMV-HA-Ets1) and the
pCMV-HA empty vector (Clontech) were kindly provided by
Dr. Satrajit Sinha (State University of New York (SUNY) at Buffalo,
Buffalo, NY). The pCMV-HA-Ets1 vector contains a Hyaluronic acid
(HA)-tagged version of the full length mouse Ets1 coding sequence
(Nagarajan et al., 2009). The Ets1 overexpression vector carrying
the variable spotting mutation (pCMV-HA-Ets1Mut) was prepared
from the PCMV-HA-Ets1 vector, using the Phusion Site-Directed
Mutagenesis Kit (Thermo Scientiﬁc), following the manufacturer's
instructions. The puriﬁed plasmid was sequenced to conﬁrm the
presence of the mutation. The Sox10-MCS4 luciferase vector
(Sox10-MCS4 fragment in pLGF-E1b vector) was generated as
previously described (Antonellis et al., 2008). The pRL-TK Renilla
luciferase control vector (Promega) was used as an internal control
for transfection efﬁciency.
Cell culture, transfections, and luciferase activity assays
The B16-F10 mouse melanoma cell line (ATCC, CRL-6322) was
cultured under standard conditions. Cells were seeded in 12 well
plates at a density of 1.5105 cells per well, roughly 24 h prior to
transfection. Once the cells reached 70–90% conﬂuency they were
co-transfected with 0.5 mg/well Sox10-MCS4 luciferase reporter
vector, 0.5 mg/well pCMV-HA-Ets1, pCMV-HA-Ets1Mut or pCMV-
HA empty vector, and 0.05 mg/well pRL-TK Renilla luciferase con-
trol vector, using the Lipofectamine 2000 lipid transfection reagent
(Life Technologies), following the manufacturer's instructions. The
cells were then incubated at 37 °C, 5% CO2 for 24 h. After 24 h, the
cells were gently washed with PBS (Thermo Scientiﬁc) and lysed
with 1 Passive Lysis Buffer (Promega), at room temperature. For
each well, 20 ml of cell lysate were used to measure ﬁreﬂy and
Renilla luciferase activities with the Dual Luciferase Reporter Assay
System (Promega) following the manufacturer's instructions.
Fireﬂy and Renilla luciferase activities were measured using a
TD-20/20 Luminometer (Turner Designs). For each experiment, the
ratio of ﬁreﬂy to Renilla luciferase activity and the fold increase in
this ratio over the ratio for the cells transfected with the PCMV-HA
empty vector were calculated. Data represent mean fold activation
over the PCMV-HA empty vector (bar height) and standard
deviation (error bars) of three independent experiments carried
out in quadruplicates. The Student's t-test was used to comparethe mean fold activation in cells transfected with the Ets1 over-
expression vector to that of cells transfected with the Ets1 over-
expression vector carrying the variable spotting mutation.Results
Variable spotting is caused by a novel missense mutation in the Ets1
gene
The spontaneous variable spotting mouse mutant exhibits a
similar pigmentation phenotype to that of mice carrying a targeted
deletion of the Ets1 gene (Barton et al., 1998), which were used in
this study. Variable spotting mutants present with white feet and
tail, and occasionally head blaze and ventral spotting, which may
be large (Jackson Laboratories). The Ets1 null mutants always have
large belly spots, hypopigmented tail and feet, and occasionally
head blaze, while only roughly 40% of Ets1 heterozygotes have
belly spots, which tend to be small in size. As part of an exome
sequencing project at the National Institutes of Health (NIH), a
possible mutation within the open reading frame (ORF) of Ets1was
identiﬁed in variable spotting. Through direct sequencing of het-
erozygous and homozygous mutants, we conﬁrmed a nucleotide
G-to-A transition in exon 3 of the Ets1 gene (Fig. 1A), which results
in a Glycine to Glutamate substitution at residue 102 (G102E) of
the Ets1 protein. Multiple sequence alignment showed that this
Glycine residue is highly conserved among different species
(Fig. 1B), which suggests that it may be important for Ets1 protein
function.
Ets1 is required for melanoblast and neural crest cell survival
The hypopigmentation phenotype observed in Ets1 hetero-
zygous and null mutant mice hinted to a potential role for Ets1 in
melanocyte development. In order to establish the earliest time
point at which Ets1 deﬁciency results in impaired melanocyte
development, Dct-LacZ transgenic mice, in which LacZ expression
is driven to melanoblasts under the control of the Dopachrome
tautomerase (Dct) promoter (Zhao and Overbeek, 1999), were used
to label melanoblasts via β-galactosidase activity in Ets1 null,
heterozygous, and wild type embryos. An apparent decrease in the
number of trunk melanoblasts was observed in E11.5–E15.5
Ets1 / embryos compared to Ets1þ / (Figs. 2, S1) and wild type
littermates (data not shown).
The marked decrease in melanoblast numbers observed in
Ets1 / embryos implied that melanoblast survival and/or pro-
liferation were likely impaired as a result of Ets1 deletion. To
establish the mechanism of action of Ets1 in murine melanocyte
development, the total numbers of trunk melanoblasts, as well as
the numbers of dying and proliferating melanoblasts, were
quantiﬁed at E10.75 (Fig. 3AG). This embryonic stage was chosen
because it was the earliest time point during which an apparent
difference in melanoblast numbers could still be detected via LacZ
staining. A signiﬁcant decrease in the number of trunk melano-
blasts was observed in Ets1 / embryos compared to Ets1þ /
littermates (p¼0.018, Fig. 3E). At this stage, the percent of pro-
liferating melanoblasts, which were identiﬁed by LacZ and phos-
pho-Histone H3 double-labeling, did not differ signiﬁcantly
between Ets1þ / and Ets1 / littermates (p¼0.852, Fig. 3F). These
results indicate that Ets1 deﬁciency does not result in impaired
melanoblast proliferation at E10.75. A signiﬁcant increase in the
percent of dying melanoblasts, which were labeled by LacZ and
Lysotracker Red staining, was observed in Ets1 / embryos com-
pared to Ets1þ / littermates (p¼0.023, Fig. 3G), suggesting that
Ets1 is required for melanoblast survival at this stage.
Fig. 1. Variable spotting is caused by a novel missense mutation in the Ets1 gene.
(A) Mutation analysis of variable spotting mice. Sequencing of heterozygous (A1)
and homozygous (A2) variable spotting mutant mice revealed a G-to-A transition
(boxes) in exon 3 of the Ets1 gene at nucleotide position 647 (RefSeq NM_011808.2).
This mutation results in a Glycine to Glutamate change at amino acid 102 (G102E)
of the Ets1 protein. (B) Multiple sequence alignment of the Ets1 protein shows that
the substituted Glycine residue (red font) is highly conserved among different
species.
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Ets1 / mutant embryos at E10.75, we investigated the possibility
that Ets1 may be required for NC cell survival prior to the speci-
ﬁcation of melanoblasts. To this end, we labeled NC cells and dying
cells via Sox10 and cleaved Caspase-3 immunostaining at E10.25 in
Ets1 / and Ets1þ / littermates (Fig. 3H and I). The transcription
factor Sox10 was chosen as a NC cell marker because it is initially
expressed in NC cells as they begin to delaminate from the neural
tube and persists in cells that will give rise to peripheral nervous
system components (Kuhlbrodt et al., 1998) and melanocytes
(Southard-Smith et al., 1998). The total number of NC cells (Sox10
positive cells) present in the anterior half of the trunk region, did
not differ signiﬁcantly between Ets1 / and Ets1þ / embryos
(p¼0.848, Fig. 3J). Nonetheless, the percent of dying NC cells in
this region (Sox10 and cleaved Caspase-3 positive cells) was sig-
niﬁcantly higher in Ets1 / embryos compared to Ets1þ / litter-
mates (p¼0.033, Fig. 3K), which suggests that Ets1 is required for
NC cell survival at this stage.
Sox10 expression was also examined at E9.5 via in situ hybridiza-
tion (Fig. S2) and LacZ staining (Fig. 6A and B) of whole embryos from
intercrosses between Ets1þ / mice or Ets1þ /::Sox10LacZ/þ mice,
respectively. At this stage, the pattern and levels of Sox10 expression
do not appear to differ between Ets1 / embryos and Ets1þ /þ or
Ets1þ / littermates. Nevertheless, Sox10 in situ hybridization revealed
ectopic Sox10 expression in the frontal aspect of the head in Ets1 /
embryos (Fig. S3B, red arrowhead). The lack of a signiﬁcant difference
in the numbers of NC cells between Ets1 / and Ets1þ / embryos atE10.25, in spite of the increased number of dying NC cells in Ets1 /
embryos, implies that Ets1 appears to act precisely around this time
point so that the effects of Ets1 deﬁciency become apparent soon
after, when a sharp decrease in melanoblast numbers is observed. The
fact that Sox10 expression did not appear to be affected in Ets1 null
mutant mice at E9.5, suggests that the critical time point at which
Ets1 regulates NC cell and melanoblast survival is somewhere
between E10 and E11.
Ets1 genetically interacts with Sox10 in melanocyte and enteric
ganglia development
The increase in melanoblast and NC cell apoptosis observed in
Ets1 null mutants, indicates that Ets1 is required early for NC cell
and melanoblast survival. Other genes required for melanoblast
survival, include those that code for the transcription factors Mitf
(microphthalmia-associated transcription factor), Sox10, and Pax3
(Paired-box 3), and for the signaling molecules Endothelin-3 (Edn3)
and Kit-ligand (Kitl), and their receptors Endothelin receptor b
(Ednrb) and Kit (reviewed in Silver et al. (2006)). Evidence from
studies in the chick embryo pointed to a potential genetic inter-
action between Ets1 and Sox10 in melanocyte development. In the
chick embryo, Ets1, along with Sox9 and c-Myb, directly binds to
and activates a Sox10 enhancer element that drives Sox10
expression to cranial NC cells (Betancur et al., 2010). In order to
determine whether a genetic interaction exists between Ets1 and
Sox10 in murine melanocyte development, Ets1þ / mice were
crossed to Sox10LacZ/þ mice and the hypopigmentation phenotypes
of the progeny were examined for three generations. For all gen-
erations, the frequency of belly spot appearance in double het-
erozygotes (Ets1þ /::Sox10LacZ/þ) was signiﬁcantly higher than in
single heterozygotes (Ets1þ / and Sox10LacZ/þ) (po0.001 for all
generations, Fig. 4A). In the three generations examined, almost all
Ets1þ /::Sox10LacZ/þ mice had belly spots (F1: 97%, F2: 96%, F3:
100%), compared to approximately 40% for Ets1þ / mice and 48%
of Sox10LacZ/þ mice. In addition to showing increased hypo-
pigmentation frequency, double heterozygous mice had belly spots
that were signiﬁcantly larger than would be expected from the
addition of the areas of the belly spots of the single heterozygotes
(po0.001 for all generations, Fig. 4B–G). These results suggest that
a synergistic genetic interaction exists between Ets1 and Sox10 in
melanocyte development.
Mutations in the transcription factor Sox10 are responsible for
Waardenburg syndrome type IV (WS4), which is characterized by
pigmentation defects and aganglionosis of the distal colon
(Hirschsprung's disease) (Pingault et al., 1998). Mutations in Sox10
have also been associated with non-syndromic Hirschsprung's
disease (Sánchez-Mejías et al., 2010). Given the importance of
Sox10 for proper enteric innervation, and the synergistic genetic
interaction between Ets1 and Sox10 in melanocyte development,
we hypothesized that Ets1 deﬁciency might also negatively affect
enteric innervation. Megacolon was observed in 2 Ets1 null mice,
both of which were heterozygous for Sox10 (Ets1 /::Sox10LacZ/þ)
(Fig. S3). In both instances, the megacolon manifested early (3.5
and 12 weeks of age) and was found to be the result of severe
hypoganglionosis of the distal colon (Fig. S3B and D). Nevertheless,
megacolon was only observed in 2 of the 7 animals that were
obtained for this genotype.
To further characterize the effect of Ets1 deﬁciency on enteric
ganglia patterning, the distal colons of animals from crosses between
Ets1þ / , Sox10LacZ/þ , and Ets1þ /::Sox10LacZ/þ mice were dissected
and subjected to Acetylcholinesterase staining to label enteric ganglia
(Fig. 5A–D). For each colon, the nerve-free (white) area in 2 mm2
within a region located 15 mm anterior to the anus, was measured
(Fig. 5E). The mean nerve-free area of colons from Ets1–/–::Sox10þ /þ
mice (n¼8, mean¼1.40270.048 mm2) was signiﬁcantly larger than
Fig. 2. Ets1 null mutant embryos have decreased numbers of melanoblasts. Dct-LacZ transgenic mice, in which LacZ expression is driven by the Dopachrome tautomerase (Dct)
promoter that drives expression to melanoblasts, were crossed to Ets1þ / mice to produce Ets1þ /::Dct-LacZþ mice. Embryos from intercrosses between Ets1þ /::Dct-LacZþ
mice were harvested between embryonic days (E)10.7515.5, subjected to LacZ staining and analyzed for the numbers and position of melanoblasts (blue dots) in the trunk
region. At all these ages, Ets1 / embryos have reduced numbers (predominantly in the areas contained within the white frames) of melanoblasts (C, D, G, H, K, L, O, P, S, T,
W, X) compared to Ets1þ / (A, B, E, F, I, J, M, N, Q, R, U, V) and wild type (not shown) littermates (HL: Hindlimb, FL: Forelimb).
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mean¼1.26070.048 mm2, p¼0.001) and Ets1þ /:: Sox10LacZ/þ
(n¼5, mean¼1.29170.075 mm2, p¼0.010) mice (Fig. 5E), suggesting
that Ets1 deﬁciency results in impaired enteric ganglia patterning in
the distal colon.
In order to explore the effect of Sox10 heterozygosity, we
compared the nerve-free areas of colons from Ets1þ /– and Ets1 /
mice that were either wild type or heterozygous for Sox10. The
mean nerve-free area in colons from Ets1þ /::Sox10þ /þ mice did
not differ signiﬁcantly (p¼1.000) from that of colons from
Ets1þ /::Sox10LacZ/þ mice (Fig. 5E). Although Sox10 heterozygosity
did not signiﬁcantly impact enteric ganglia patterning in Ets1
heterozygotes, the colons of Ets1 null mutants that were also
heterozygous for Sox10 had signiﬁcantly larger nerve-free areas(n¼5, mean¼1.50170.081 mm2) compared to those of Ets1 null
mutants that were wild type for Sox10 (p¼0.017, Fig. 5E). Thus,
Ets1 null mutants had nerve free areas that were signiﬁcantly
larger than Ets1 heterozygotes when they were wild type or het-
erozygous for Sox10.
These results provide evidence to support the presence of a genetic
interaction between Ets1 and Sox10 in the development of enteric
ganglia. Although the colons from the two Ets1 /::Sox10LacZ/þ ani-
mals in which megacolon was detected (Fig. S2) were not included in
this analysis, as these were considered extreme cases, the occurrence
of megacolon in these mice further supports the possibility that Ets1
and Sox10 interact in enteric ganglia development.
The synergistic genetic interaction observed between Ets1 and
Sox10 pointed to a potential functional interaction between these
Fig. 3. Ets1 is required for melanoblast and neural crest cell survival. (A, C) Melanoblasts traveling along the surface of the embryo are marked via LacZ staining (black
asterisks). (B) Proliferating cells are positive for the phospho-Histone H3 (p-Histone H3) antibody (green ﬂuorescence). (D) Lysotracker Red marks lysosomes in dying cells
(red ﬂuorescence). (A, B) Proliferating melanoblasts (*) are LacZ and p-Histone H3 positive. (C, D) Dying melanoblasts (**) are LacZ and Lysotracker Red positive.
(E) Melanoblasts, (F) proliferating melanoblasts and (G) dying melanoblasts were counted in 80 sections for E10.75 Ets1þ / (n¼3) and Ets1 / (n¼3) embryos. (E) Ets1 /
embryos have signiﬁcantly reduced numbers of melanoblasts compared to Ets1þ / littermates (*po0.05). (F) The percent of proliferating melanoblasts did not differ
signiﬁcantly between Ets1 / and Ets1þ / littermates (p¼0.852), (G) while the percent of dying melanoblasts was signiﬁcantly higher (*po0.05) in Ets1 / embryos
compared to Ets1þ / littermates. (H–K) Sox10 and cleaved Caspase-3 double-label immunoﬂuorescence of E10.25 mouse embryos. Neural crest (NC) cells were labeled via
Sox10 antibody staining (red ﬂuorescence). Dying cells were labeled using a cleaved Caspase-3 antibody (green ﬂuorescence). (J, K) Dying NC cells are positive for Sox10 and
cleaved Caspase-3 (white arrows). (L) NC cells and (M) dying NC cells were counted in 35 sections spanning the anterior half of the trunk region for E10.25 Ets1þ / (n¼3)
and Ets1 / (n¼3) embryos. (J) The number of NC cells in Ets1 / embryos is not signiﬁcantly different from that of Ets1þ / littermates (p¼0.848). (K) The percent of dying
NC cells is signiﬁcantly higher (*po0.05) in Ets1 / embryos compared to Ets1þ / littermates (scale bars¼50 mm).
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Given that Ets1 is required for Sox10 expression in the chick cranial
NC (Betancur et al., 2010), it is possible that it could also be an
important regulator of Sox10 expression in the mouse embryo. In
order to visualize gross changes in Sox10 expression in Ets1 null
mutants, embryos from intercrosses between Ets1þ /::Sox10LacZ/þ
mice were harvested at E9.5, E11.5, and E12.5 and Sox10 expression
was analyzed via LacZ staining. At E9.5, no apparent changes in LacZ
staining were detected in Ets1 / embryos compared to Ets1þ /þ
(Fig. 6A and B) and Ets1þ / littermates (not shown). At E11.5, LacZ
staining was reduced in 75% of the Ets1 / (n¼4) embryos (Fig. 6D)
examined compared to Ets1þ /þ (n¼3) (Fig. 6C) and Ets1þ / (n¼3)
(not shown) littermates. At E12.5, a decrease in LacZ staining wasobserved in 50% of Ets1 / (n¼6) embryos (Fig. 6F) compared to
Ets1þ /þ (n¼3) (Fig. 6E) and Ets1þ / (n¼9) (not shown) littermates.
The changes in LacZ staining observed in Ets1 null mutant embryos
suggest that Ets1 may regulate Sox10 expression during embryonic
development. However, these changes could also be the result of a
decrease in the number of NC cell derivatives, thus the numbers of
Sox10 positive cells in the dorsal root ganglia, where LacZ staining
was reduced, were quantiﬁed for E12.5 Ets1 / (n¼3) and Ets1þ /þ
(n¼3) embryos. The average number of Sox10 positive cells in the
dorsal root ganglia was not signiﬁcantly different (p¼0.753)
between Ets1 / and wild type embryos, indicating that the
decreased intensity in LacZ staining observed in Ets1 / embryos is
Fig. 4. Ets1 and Sox10 interact synergistically in melanocyte development. (A) The incidence of hypopigmentation in Ets1þ /::Sox10LacZ/þ mice was signiﬁcantly greater than
the incidence of hypopigmentation in Ets1þ / and Sox10LacZ/þ mice (po0.001) for all three generations analyzed (nZ17 for each genotype, for all generations). (B, C, D)
Representative pictures of ventral hypopigmentation for each genotype show that double heterozygous mice had larger areas of hypopigmentation compared to Ets1 and
Sox10 single heterozygotes. (E, F, G) The areas of hypopigmentation in Ets1þ / , Sox10þ / , and Ets1þ /::Sox10LacZ/þ were measured for progeny from 3 generations. The
transformed areas of the belly spots of Ets1þ /::Sox10LacZ/þ mice were signiﬁcantly greater than the sum of the transformed areas of the belly spots of Ets1þ / and
Sox10LacZ/þ mice (po0.001) in all three generations examined.
A. Saldana-Caboverde et al. / Developmental Biology 407 (2015) 300–312 307not caused by a decrease in the number of Sox10-positive NC
derivatives.
Ets1 transactivates a neural crest-lineage speciﬁc Sox10 regulatory
region
Although many transcriptional targets of Sox10 have been
identiﬁed, the various aspects of Sox10 regulation are only now
beginning to be understood. The Sox10 promoter, which has not
been well characterized, does not direct the expression of Sox10 to
most of its typical expression sites (Deal et al., 2006). However, 14
multiple conserved sequences (MCS) that can drive Sox10
expression to various cell lineages have been described (Antonellis
et al., 2006, 2008; Deal et al., 2006). A subset of these sequences
was ﬁrst identiﬁed by mutation analysis of the transgene-insertion
Sox10Hry mutant, a mouse model of WS4. In this mutant, a 16 kb
area located 47 kb upstream of Sox10 is deleted (Antonellis et al.,
2008). This deletion severely impairs but does not completely
abrogate Sox10 expression, suggesting that this 16 kb region con-
tains cis-regulatory elements necessary for Sox10 expression. Of
these elements, Sox10-MCS1c, Sox10-MCS4, Sox10-MCS5, Sox10-
MCS7, and Sox10-MCS9 can drive reporter gene expression in
cultured melanocytes. Furthermore, both Sox10-MCS4 and Sox10-
MCS7 are able to recapitulate Sox10 expression in vivo, in almost
all NC-derived structures, including melanocytes and enteric
ganglia, where Sox10 is normally expressed (Antonellis et al.,
2008). Analysis of the 820 bp sequence of the Sox10-MCS4enhancer using the MatInspector software (Genomatix, Inc.)
revealed the presence of 4 potential Ets1 binding sites (Table S1).
The ability of Ets1 to activate the Sox10-MCS4 enhancer was tested
via luciferase reporter assay in B16-F10 mouse melanoma cells.
Compared to cells transfected with the empty PCMV-HA vector,
cells transfected with an Ets1 overexpression vector (PCMV-HA-
Ets1) showed approximately a 6.5-fold increase in luciferase
activity (Fig. 7).
In light of the fact that Ets1 is able to transactivate the Sox10-
MCS4 enhancer in mouse melanoma cells, Sox10 expression, as
well as the expression of other melanoblast-speciﬁc genes, was
evaluated in mouse melanocytes (melan-a) and melanoma cells
(B16-F10) in which Ets1 was either overexpressed or knocked-
down. In mouse melanocytes, we failed to detect substantial
changes in the expression levels of Kit, Ednrb, Pax3, Mitf, and Sox10
in cells transfected with an Ets1 overexpression vector, compared
to cells transfected with an empty vector (Fig. S4B). Similarly, no
considerable changes in the expression levels of Kit, Pax3,Mitf, and
Sox10were detected in mouse melanoma cells overexpressing Ets1
(Fig. S4D).
Given the lack of substantial changes in the expression of
melanoblast-speciﬁc genes as a result of Ets1 overexpression, we
assessed the effect of Ets1 knockdown on the expression of these
genes. For both cell lines, no substantial changes on the expression
levels of Pax3, Mitf, Sox10, and Kit were detected (Fig. S5). We
observed a slight upregulation in Ednrb expression (fold
change¼2.00670.087), in mouse melanocytes transfected with
Fig. 5. Ets1 null mutants show deffects in enteric ganglia patterning. (A–D) Representative images of enteric ganglia labeled via Acetylcholinesterase staining in the distal
colons from (A) Ets1þ /::Sox10þ /þ , (B) Ets1þ /::Sox10LacZ/þ , (C) Ets1 /::Sox10þ /þ , and (D) Ets1 /::Sox10LacZ/þ mice (scale bars¼1 mm). Scatterplot showing the nerve-
free areas (including means and standard deviations) in 2 mm2 regions of the distal colons from mice of each genotype. The mean nerve-free area in colons from
Ets1þ /::Sox10þ /þ mice did not differ signiﬁcantly from that of Ets1þ /::Sox10LacZ/þ (p¼1.000) mice. The mean nerve-free area of colons from Ets1 /::Sox10þ /þ mice was
signiﬁcantly larger than the mean nerve-free areas of colons from Ets1þ /::Sox10þ /þ (**po0.005) and Ets1þ /::Sox10LacZ/þ (*po0.05) mice. The mean nerve-free area of
the colons from Ets1 /::Sox10LacZ/þ mice was signiﬁcantly greater compared to that of colons from Ets1þ /::Sox10þ /þ (***po0.001), Ets1þ /::Sox10LacZ/þ (**po0.005), and
Ets1 /::Sox10þ /þ (*po0.05) mice.
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was not observed in cells transfected with an Ets1 siRNA pool (Fig.
S5B). These results suggest that at least within the context of
melanoma cells and differentiated melanocytes, Ets1 does not
appear to regulate the expression levels of Sox10, Pax3, Mitf, Kit,
and Ednrb.The variable spotting mutation inhibits Sox10-MCS4 enhancer
activation
The variable spotting mutation results in the substitution of a
highly conserved Glycine (G102) residue. The G102 residue is present
within the Pointed (PNT) domain of the Ets1 protein. This domain
Fig. 6. Sox10 expression is not altered at E9.5 but is reduced at E11.5 and E12.5 in some Ets1 null mutant embryos. (A–F) Sox10 expression was visualized via LacZ staining in
embryos from intercrosses between Ets1þ /::Sox10LacZ/þ mice. (A, B) At E9.5, no gross differences were observed in LacZ expression between Ets1 / and Ets1þ /þ or Ets1þ /
(not shown) littermates. (C, D) At E11.5, LacZ expression was reduced in 75% of Ets1 / embryos (n¼4) (D), compared to Ets1þ / (n¼3) (not shown) and Ets1þ /þ (n¼3)
(C) littermates. (E, F) At E12.5, a decrease in LacZ expression was observed in 50% of Ets1 / (n¼6) (F) embryos compared to Ets1þ / (n¼9) (not shown), and Ets1þ /þ (E)
(n¼3) littermates. (GK) Sox10 positive cells in the dorsal root ganglia were quantiﬁed in 15 sections spanning the trunk region for Ets1þ /þ (n¼3) (G, I) and Ets1 / (n¼3)
(H, J) embryos at E12.5. (K) At this stage, no signiﬁcant differences in the numbers of Sox10 positive cells present within the dorsal root ganglia were observed between
Ets1þ /þ and Ets1 / littermates (p¼0.753). (Magniﬁcations: A, B¼40 , C, D¼25 , E, F¼21 ) (cg: cranial ganglia, ot: otocyst, drg: dorsal root ganglia, ba1: ﬁrst branchial
arch, ba2: second branchial arch) (scale bars¼100 mm).
Fig. 7. Activation of the Sox10-MCS4 enhancer by wild type and mutant Ets1. B16
mouse melanoma cells were co-transfected with the Sox10-MCS4 luciferase
reporter vector, the pRL-TK Renilla luciferase control vector, and either the PCMV-
HA empty vector (–), or an expression vector encoding an HA-tagged version of the
full length wild type (Ets1) or mutant (Ets1Mut) mouse Ets1 coding sequence. Ets1
was found to activate the Sox10-MCS4 enhancer. The presence of the variable
spotting mutation resulted in a signiﬁcant decrease in Sox10-MCS4 enhancer acti-
vation (**po0.005). The ﬁreﬂy luciferase activity was normalized by Renilla luci-
ferase activity. Data represent mean fold activation over the PCMV-HA empty
vector (bar height) and standard deviation (error bars) of 3 independent experi-
ments carried out in quadruplicates.
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site for the mitogen-activated protein kinase (MAPK) ERK2 (Seidel
and Graves, 2002). Docking of ERK2 at this site is critical for the
phosphorylation of a threonine residue (T38) that is required forenhanced transcriptional activation by Ets1 via recruitment of the
transcription factor CREB-binding protein (CBP) (reviewed in Gar-
rett-Sinha (2013)). In order to test whether the variable spotting
mutation affects the ability of Ets1 to activate the Sox10-MCS4
enhancer, the mutation was inserted into the Ets1 ORF via site-
directed mutagenesis. A signiﬁcant decrease in relative luciferase
activity was observed in cells transfected with the Ets1 over-
expression vector carrying the variable spotting mutation compared
to those transfected with the wild type Ets1 overexpression vector
(p¼0.0022) (Fig. 7). This decrease corresponds to approximately a
49% reduction in Sox10-MCS4 enhancer activation.Discussion
In the present study, we provide evidence to support a role for
the transcription factor Ets1 in NC cell and melanoblast survival,
and show that it interacts with Sox10 to promote proper mela-
nocyte and enteric ganglia development. In vivo analysis revealed
a signiﬁcant increase in melanoblast cell death and a concomitant
decrease in melanoblast numbers as early as E10.75 in Ets1 null
mutants compared to heterozygous littermates. The early survival
defect observed in the melanoblast population in Ets1 null mutant
mice suggests that Ets1may be involved in the regulation of one or
more early melanoblast-speciﬁc genes. Given the increase in
melanoblast cell death observed in Ets1 null mutants at E10.75, it
was plausible that Ets1 may regulate the survival of NC cells prior
to their speciﬁcation into the melanocyte lineage. Although no
signiﬁcant differences in the numbers of trunk NC cells were
observed between E10.25 Ets1 null and heterozygous littermates, a
signiﬁcant increase in the number of dying NC cells was observed
in Ets1 null mutants. These results indicate that Ets1 acts as a
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the melanocytic lineage, and melanocyte precursors. Although the
presence of viable melanocytes in adult Ets1 null mutants indi-
cates that Ets1 is not essential for proper melanocyte differentia-
tion, it is possible that the large decrease in melanoblast cell
numbers observed in these mice could in part arise as a con-
sequence of altered NC cell fate decisions. The presence of ectopic
NC cell-derived cartilage nodules in the hearts of Ets1 null mutant
mice suggests that Ets1 may act as a negative regulator of cartilage
fate in NC cells (Gao et al., 2010). Consequently, in spite of the
melanoblast survival defect observed in Ets1 null mutants, we
cannot discard the possibility that in addition to being required for
melanoblast survival, Ets1 may also be involved in NC migration
and or in cell lineage speciﬁcation.
Other pigmentation mutants in which melanoblast survival
defects are observed as early as E10.5–E11.5 include mutants of the
transcription factors Sox10, Pax3, and Mitf as well as mutants of the
G-coupled Endothelin receptor b (Ednrb) and the tyrosine kinase
receptor Kit. Mutations in these genes not only affect melanoblast
survival, but also proliferation, migration and ﬁnal differentiation
(reviewed in Baxter et al., (2004) and Silver et al. (2006)). The
transcription factors Pax3 and Sox10 are initially expressed in NC cells
at E8.5 prior to their commitment into the melanocytic fate.Mitf, Kit,
and Ednrb, on the other hand, are ﬁrst expressed between E10 and
E10.5, around the time of melanoblast speciﬁcation from the NC
(reviewed in Silver et al. (2006)). All of these genes are required for
melanoblast survival and it is possible that the Ets1-induced effect
on melanoblast survival is mediated via one or more of these critical
melanocytic genes. Of these genes, we considered Sox10 as the most
likely downstream effector of Ets1 based on evidence from studies in
the avian system. In the chick embryo, Ets1 drives Sox10 expression
in cranial NC cells by directly binding to and activating the Sox10E2
enhancer, which is critical for the initiation of Sox10 expression in
cranial NC cells (Betancur et al., 2010). The hypopigmentation phe-
notype observed in Ets1 null mutant mice results from defects in the
development of melanocytes derived from trunk NC cells. As such, it
is conceivable that in the mouse Ets1 regulates Sox10 expression in
the trunk NC. In order to determine whether a genetic interaction
exists between Ets1 and Sox10 in melanocyte development, we
compared the pigmentation phenotypes of single and double het-
erozygous progeny from crosses between Ets1þ / and Sox10LacZ/þ
mice. Ets1þ / and Sox10LacZ/þ mice were generated in different
genetic backgrounds; for this reason, three generations of mice were
examined in order to take into account the potential effect of back-
ground modiﬁers. A signiﬁcant increase in the frequency of belly
spot appearance was observed in double heterozygous mice com-
pared to single heterozygotes. Analysis of the belly spot areas of each
mouse revealed that the mean areas of hypopigmentation in double
heterozygous mice were signiﬁcantly larger than the sum of the
areas of hypopigmentation in single heterozygotes. These results
were consistent and signiﬁcant across all generations and indicate
that a synergistic genetic interaction exists between Ets1 and Sox10
in melanocyte development. The fact that the results were consistent
across all generations suggests that the presence of strain-speciﬁc
alleles did not seem to signiﬁcantly affect the penetrance of the
hypopigmentation phenotype in these mice.
Whether synergistic genetic interactions indicate the presence of
an underlying functional relationship remains controversial (Perez-
Perez et al., 2009). Synergistic genetic interactions identiﬁed through
the study of double heterozygous pigmentation mutants have often
been found to be the result of molecular interactions between the
genes in question. The presence of a synergistic genetic interaction
between the transcription factor Mitf and the tyrosine kinase
receptor Kit was the ﬁrst indication that these genes work together
in the modulation of pigment production. Mice heterozygous for a
semi-dominant Mitf mutation (Mitfmi-wh/þ) have a uniform ventralspot and a light coat color. Crossing Mitfmi-wh/þ mice to mice het-
erozygous for a semi-dominant mutation in Kit (KitW-36H), which
only have ventral spots and occasionally white feet and tail, resulted
in an exacerbated pigmentation phenotype, which was more severe
than expected if the hypopigmented areas of the single hetero-
zygotes were added (Beechey and Harrison, 1994). Similar results
were obtained when Mitfmi-wh/þ mice were crossed to heterozygous
mice in which the LacZ gene was inserted into the Kit locus
(KitW-LacZ/þ). Additional experiments demonstrated that signaling via
the Kit receptor modulates Mitf and is required for Mitf-dependent
induction of Tyrosinase (Tyr), a rate limiting enzyme in melanin
production (Hou et al., 2000). The study of double heterozygous
pigmentation mutants has also revealed the presence of synergistic
interactions resulting from underlying molecular interactions
between Mitf and the anti-apoptotic factor Bcl2 (McGill et al., 2002)
and between the transcription factors Pax3 and Kit (Guo et al., 2010).
To determine whether the synergistic genetic interaction between
Ets1 and Sox10 in melanocyte development could be the result of an
underlying functional interaction, we examined Sox10 expression in
Ets1mutant mice using the Sox10LacZ transgenic system. A decrease in
LacZ expressionwas observed in at least half of all E11.5 and E12.5 Ets1
null embryos compared to Ets1 heterozygous and wild type litter-
mates suggesting that Ets1 may play a role in the regulation of Sox10
expression. In order to gain a better understanding of the underlying
functional interaction that may exist between Ets1 and Sox10, the
ability of wild type and mutated Ets1 protein to activate the Sox10-
MCS4 enhancer, which is critical for Sox10 expression in mouse mel-
anocytes (Antonellis et al., 2008) was investigated. Analysis of the
Sox10-MCS4 sequence revealed the presence of four potential binding
sites for Ets1 suggesting the possibility that Ets1 could regulate Sox10
expression via this enhancer. Through luciferase reporter assays we
showed that Ets1 is able to drive reporter gene expression through
Sox10-MCS4. We also showed that the variable spotting mutation,
which we determined to be a mutation in the Ets1 ORF, results in a
signiﬁcant reduction in Sox10-MCS4 enhancer activation. These data
suggest that the pigmentation defect observed in Ets1 mutant mice
may, at least in part, be the result of decreased Sox10 expression. In
spite of this, we did not observe substantial changes in Sox10
expression in mouse melanocytes or melanoma cells in which Ets1
was knocked-down or overexpressed. It is possible that in the mouse
melanocyte and melanoma cell lines used for these experiments other
factors might be able to compensate for Ets1 deﬁciency. In the case of
Ets1 overexpression, the absence of a signiﬁcant change in the
expression of Sox10 or other potential downstream targets could
result if endogenous Ets1 protein is sufﬁcient to drive the expression
of said targets, and thus the regulatory regions of these genes are
already saturated by the endogenous protein. Additional experiments
in NC cells and melanoblasts, aimed at understanding the effects of
Ets1 overexpression and knockdown on Sox10 expression, are needed
to further characterize the functional relationship between Ets1 and
Sox10 in melanocyte development.
The presence of a spontaneous mutation in Ets1which results in a
pigmentation phenotype provided the opportunity to validate the
ﬁnding that Ets1 can drive expression through Sox10-MCS4.
Although the G102E Ets1 mutant protein is able to activate the
Sox10-MCS4 enhancer, reporter gene expression is reduced by
approximately 49% compared to the wild type Ets1 protein. These
results suggest that the variable spotting mutation is hypomorphic,
because it reduces but does not completely abrogate Ets1 protein
function. The Glycine residue mutated in the spontaneous variable
spotting mutant is present within the PNT domain, an important
functional domain of the Ets1 protein that enhances the transacti-
vation activity of Ets1. The PNT domain contains a docking site for
ERK2 (Seidel and Graves, 2002). Docking of ERK2 at this site is critical
for the phosphorylation of a threonine residue that is required for
enhanced transcriptional activation by Ets1 via recruitment of the
A. Saldana-Caboverde et al. / Developmental Biology 407 (2015) 300–312 311transcription factor CBP (reviewed in Garrett-Sinha, 2013). Mutating
this ERK2 docking site was previously found to abrogate Ras/MAPK-
mediated enhancement of Ets1 transactivation activity to the same
degree as mutating the phosphoacceptor T38 residue (Seidel and
Graves, 2002). Three residues within the PNT domain of Ets1, Leucine
114 (L114), L116 and Phenylalanine 120 (F120) have been shown to
play a role in ERK2 binding (Seidel and Graves, 2002). Given the
reduced Ets1 transactivation activity of the variable spotting mutant
protein, it is possible that the G102 residue may be important for
docking of ERK2 and T38 phosphorylation; nonetheless, the hypo-
morphic nature of the G102E mutation suggests that this residue
although important, is likely not essential. It is also possible that the
effect of the variable spotting mutation on Sox10-MCS4 activation is
not related to ERK2 docking and subsequent T38 phosphorylation.
Phosphorylation of T38 is important for Ets1 activation of Ras-
responsive genes (Seidel and Graves, 2002). To date, no evidence
exists to support a direct role for the MAPK pathway in Sox10 acti-
vation in the melanocyte lineage. Additionally the G102E mutation is
located outside of the (114) LXLXXXF(120) domain, which is crucial
for ERK docking (Dittmer, 2003). Additional studies are needed to
dissect the speciﬁc mechanism via which the variable spotting
mutation results in decreased Sox10-MCS4 activation.
In addition to being required for proper melanocyte development,
Sox10 is also required for the development of enteric ganglia (South-
ard-Smith et al., 1998). In the spontaneous embryonic lethal
Sox10Dom/Dom mutant mouse, NC cells fail to colonize the intestine as a
result of increased apoptosis (Kapur, 1999). This may be the result, at
least in part, of decreased activation of the tyrosine kinase receptor
c-Ret, which is also required for the development of enteric ganglia,
and has been shown to be activated by Pax3 and Sox10 (Lang et al.,
2000). The requirement of Sox10 for the survival of enteric ganglia
precursors prompted us to examine the colons of Ets1 null mutant
mice to determine whether Ets1 deﬁciency would negatively affect
enteric innervation. Ets1 null mice had signiﬁcantly decreased enteric
innervation in the distal colon, compared to heterozygotes, indicating
that Ets1 may also be important for the development of enteric
ganglia. In view of the role of Ets1 in NC cell survival, it is possible that
the defect in enteric ganglia patterning observed in Ets1 null mutant
mice may be the result of a reduction in the number of NC cells
available to colonize the distal colon.
Throughout the course of the present study, two instances of
severe hypoganglionic megacolon were observed in Ets1 null mutant
mice, which were also heterozygous for Sox10 (Ets1 /::Sox10LacZ/þ)
(Fig. S2). Although no signiﬁcant difference in the extent of enteric
innervation was observed between Ets1þ /::Sox10þ /þ and
Ets1þ /::Sox10LacZ/þ mice, Ets1 /::Sox10LacZ/þ mice were found to
have colons with greater nerve-free areas compared to Ets1 / mice
that were wild type for Sox10. The signiﬁcant decrease in enteric
innervation observed in Ets1 /::Sox10LacZ/þ mice compared to
Ets1 /::Sox10þ /þ may be the result of a synergistic interaction
between Ets1 and Sox10. In light of the absence of a signiﬁcant dif-
ference in enteric innervation between Ets1þ /::Sox10þ /þ and
Ets1þ /::Sox10LacZ/þ mice and the embryonic lethality of Sox10LacZ/LacZ
mutants, it was not possible to directly test the presence of a syner-
gistic genetic interaction using double null mutant mice. Nevertheless,
the decreased enteric innervation observed in Ets1 /::Sox10LacZ/þ
mice compared to Ets1 /::Sox10þ /þ mice and the presence of
hypoganglionic megacolon in 2 of the 7 Ets1 /::Sox10LacZ/þ mice
examined suggests that Ets1 and Sox10 may interact in the develop-
ment of enteric ganglia. Our ﬁnding that Ets1 promotes the survival
NC cells is also consistent with this hypothesis. A decrease in enteric
progenitor cell survival has been described in Sox10 heterozygous
mice that are also homozygous for the mutant Ednrbsl/sl (piebald) or
Edn3ls/ls (lethal spotting) alleles. Compared to single mutants, these
animals show a dramatic decrease in the number of enteric neuronal
progenitor cells in the digestive tract, which results from increasedapoptosis in vagal NC cells prior to the timewhen they begin to invade
the digestive tract at E9.5–10 (Stanchina et al., 2006). In Sox10
homozygous mutants, increased apoptosis of enteric ganglia precursor
cells also results in the failure of these cells to colonize the intestines
(Kapur, 1999).
Taken together, the results of this study suggest that Ets1 is
required for proper NC cell and melanoblast survival, possibly acting
upstream of Sox10. Our data indicate that Ets1 and Sox10 act syner-
gistically during melanocyte development and may also interact in
enteric ganglia development. Furthermore, the ability of Ets1 to
activate a Sox10 regulatory region that is required for Sox10 expres-
sion in melanocytes and enteric ganglia, suggests that the synergistic
genetic interaction that exists between Ets1 and Sox10 may be the
result of an interaction at the molecular level. Additional studies are
needed to determine if this interplay also acts in other neural crest
derivatives. In the present study, we also identiﬁed a spontaneous
Ets1 mouse pigmentation mutant, and characterized the negative
effect of this mutation on the ability of Ets1 to activate a Sox10
regulatory region. Additional studies are warranted to characterize
the molecular aspects of the interaction between Ets1 and Sox10 and
the mechanism via which the variable spotting mutation may impair
this interaction. The results of this study in combination with the
future work proposed will provide a better understanding of the
gene regulatory network directing melanocyte development. A
detailed characterization of this network is critical because altera-
tions in genes required for the development of melanocytes and
other NC cell derivatives have been recognized in several human
pathological conditions, including cancer.Acknowledgments
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